MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.600
-0.160 (-9.09%)
At close: Dec 20, 2024, 4:00 PM
1.620
+0.020 (1.26%)
After-hours: Dec 20, 2024, 7:32 PM EST
MetaVia Market Cap
MetaVia has a market cap or net worth of $13.79 million as of December 20, 2024. Its market cap has decreased by -30.22% in one year.
Market Cap
13.79M
Enterprise Value
-7.74M
1-Year Change
-30.22%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $9.49B to $13.79M, a decrease of -99.85%. That is a compound annual growth rate of -73.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 13.79M | -23.13% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | 86.24M | -99.09% |
| Dec 31, 2019 | 9.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioXcel Therapeutics | 14.58M |
| ProPhase Labs | 14.58M |
| Streamline Health Solutions | 14.46M |
| Acurx Pharmaceuticals | 13.94M |
| Innovative Eyewear | 13.92M |
| ImmunoPrecise Antibodies | 13.42M |
| Impact BioMedical | 13.34M |
| Lifeward | 13.21M |